STAT+: RevMed’s pancreatic cancer drug nears European approval
Following a green light from the FDA, European regulators have now recommended the approval of Revolution Medicines' Rasonque for pancreatic cancer.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.